EE03380B1 - Farmatseutiline aerosoolpreparaat ja selle valmistamismeetod - Google Patents

Farmatseutiline aerosoolpreparaat ja selle valmistamismeetod

Info

Publication number
EE03380B1
EE03380B1 EE9700061A EE9700061A EE03380B1 EE 03380 B1 EE03380 B1 EE 03380B1 EE 9700061 A EE9700061 A EE 9700061A EE 9700061 A EE9700061 A EE 9700061A EE 03380 B1 EE03380 B1 EE 03380B1
Authority
EE
Estonia
Prior art keywords
preparation
aerosol formulation
pharmaceutical aerosol
pharmaceutical
formulation
Prior art date
Application number
EE9700061A
Other languages
English (en)
Other versions
EE9700061A (et
Inventor
Arthur Johnson Keith
Li-Bovet Li
Original Assignee
Glaxo Wellcome Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Wellcome Inc. filed Critical Glaxo Wellcome Inc.
Publication of EE9700061A publication Critical patent/EE9700061A/et
Publication of EE03380B1 publication Critical patent/EE03380B1/et

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/10—Phosphatides, e.g. lecithin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
EE9700061A 1994-09-28 1995-09-27 Farmatseutiline aerosoolpreparaat ja selle valmistamismeetod EE03380B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9419536A GB9419536D0 (en) 1994-09-28 1994-09-28 Medicaments
PCT/IB1995/000866 WO1996009816A1 (en) 1994-09-28 1995-09-27 Medicaments

Publications (2)

Publication Number Publication Date
EE9700061A EE9700061A (et) 1997-08-15
EE03380B1 true EE03380B1 (et) 2001-04-16

Family

ID=10762008

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9700061A EE03380B1 (et) 1994-09-28 1995-09-27 Farmatseutiline aerosoolpreparaat ja selle valmistamismeetod

Country Status (32)

Country Link
US (1) US5849265A (et)
EP (1) EP0783302B1 (et)
JP (1) JPH10506887A (et)
KR (1) KR100375469B1 (et)
CN (1) CN1084614C (et)
AP (1) AP742A (et)
AT (1) ATE187063T1 (et)
AU (1) AU707922B2 (et)
BG (1) BG62839B1 (et)
BR (1) BR9509108A (et)
CZ (1) CZ286356B6 (et)
DE (1) DE69513671T2 (et)
DK (1) DK0783302T3 (et)
EE (1) EE03380B1 (et)
ES (1) ES2140706T3 (et)
FI (1) FI971279L (et)
GB (1) GB9419536D0 (et)
GE (1) GEP20002140B (et)
GR (1) GR3032245T3 (et)
HU (1) HU221856B1 (et)
IS (1) IS1991B (et)
MD (1) MD1900C2 (et)
MX (1) MX9702149A (et)
NO (1) NO313658B1 (et)
NZ (1) NZ292995A (et)
OA (1) OA10603A (et)
PL (1) PL181453B1 (et)
RO (1) RO118564B1 (et)
RU (1) RU2157188C2 (et)
SK (1) SK281519B6 (et)
UA (1) UA47412C2 (et)
WO (1) WO1996009816A1 (et)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9410222D0 (en) * 1994-05-21 1994-07-06 Glaxo Wellcome Australia Ltd Medicaments
US6039932A (en) * 1996-09-27 2000-03-21 3M Innovative Properties Company Medicinal inhalation aerosol formulations containing budesonide
US6598603B1 (en) * 1997-12-31 2003-07-29 Astra Aktiebolag Method for treating respiratory diseases
US6984404B1 (en) 1998-11-18 2006-01-10 University Of Florida Research Foundation, Inc. Methods for preparing coated drug particles and pharmaceutical formulations thereof
DE60001492T2 (de) * 1999-04-14 2003-12-18 Glaxo Group Ltd., Greenford Pharmazeutische aerosolformulierung
US6406745B1 (en) 1999-06-07 2002-06-18 Nanosphere, Inc. Methods for coating particles and particles produced thereby
GB0009606D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Therapeutic combinations
US6451287B1 (en) 2000-05-26 2002-09-17 Smithkline Beecham Corporation Fluorinated copolymer surfactants and use thereof in aerosol compositions
GB0016876D0 (en) * 2000-07-11 2000-08-30 Astrazeneca Ab Novel formulation
US6777400B2 (en) * 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
CZ304043B6 (cs) * 2000-08-05 2013-09-04 Glaxo Group Limited Estery steroidních thiokyselin
GB0019172D0 (en) * 2000-08-05 2000-09-27 Glaxo Group Ltd Novel compounds
US6858593B2 (en) * 2000-08-05 2005-02-22 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6759398B2 (en) * 2000-08-05 2004-07-06 Smithkline Beecham Corporation Anti-inflammatory androstane derivative
US6858596B2 (en) * 2000-08-05 2005-02-22 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivative
US6787532B2 (en) * 2000-08-05 2004-09-07 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivatives
US6750210B2 (en) * 2000-08-05 2004-06-15 Smithkline Beecham Corporation Formulation containing novel anti-inflammatory androstane derivative
US6777399B2 (en) * 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
JP2004509159A (ja) 2000-09-22 2004-03-25 グラクソ　グループ　リミテッド 新規なアルカン酸誘導体
GB0106046D0 (en) 2001-03-12 2001-05-02 Glaxo Group Ltd Canister
UA77656C2 (en) * 2001-04-07 2007-01-15 Glaxo Group Ltd S-fluoromethyl ester of 6-alpha, 9-alpha-difluoro-17-alpha-[(2-furanylcarbonyl)oxy]-11-beta-hydroxy-16- alpha-methyl-3-oxoandrosta-1,4-dien-17-beta-carbothioacid as anti-inflammatory agent
US6667344B2 (en) 2001-04-17 2003-12-23 Dey, L.P. Bronchodilating compositions and methods
US7291608B2 (en) * 2001-04-30 2007-11-06 Glaxo Group Limited Anti-inflammatory 17.β.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.α
ES2307751T3 (es) * 2001-06-12 2008-12-01 Glaxo Group Limited Nuevos esteres heterociclicos centi-inflamatorios 17 alfa de derivados 17 beta de carbotioato de androstano.
GB0118364D0 (en) * 2001-07-27 2001-09-19 Glaxo Group Ltd Compounds
ES2293157T3 (es) * 2001-08-03 2008-03-16 Glaxo Group Limited Compuestos tensioactivos y uso de los mismos.
GB0125127D0 (en) 2001-10-19 2001-12-12 Glaxo Group Ltd Compounds
US6702997B2 (en) 2001-10-26 2004-03-09 Dey, L.P. Albuterol inhalation solution, system, kit and method for relieving symptoms of pediatric asthma
US20030140920A1 (en) * 2001-10-26 2003-07-31 Dey L.P. Albuterol inhalation soultion, system, kit and method for relieving symptoms of pediatric asthma
US20030203930A1 (en) * 2001-10-26 2003-10-30 Imtiaz Chaudry Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease
JP2003221335A (ja) 2001-10-26 2003-08-05 Dey Lp 慢性閉塞性肺疾患の症状を緩和するためのアルブテロールおよびイプラトロピウム吸入溶液、システム、キットおよび方法
US20030191151A1 (en) * 2001-10-26 2003-10-09 Imtiaz Chaudry Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease
US20050175545A1 (en) * 2002-02-04 2005-08-11 Keith Biggadike Formulation for inhalation comprising a glucocorticoid and a beta 2-adrenoreceptor agonist
GB0202635D0 (en) * 2002-02-05 2002-03-20 Glaxo Wellcome Mfg Pte Ltd Formulation containing novel anti-inflammatory androstane derivative
CA2474626A1 (en) 2002-02-13 2003-08-21 Glaxo Group Limited Carboxylic acid compounds for use as surfactants
GB0205327D0 (en) * 2002-03-06 2002-04-17 Glaxo Group Ltd compounds
GB2389530B (en) * 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
ES2449718T3 (es) 2003-08-11 2014-03-20 Glaxo Group Limited Inhalador de dosis farmacéutica medida y procedimiento relacionados con el mismo
MXPA06002075A (es) 2003-08-29 2006-05-19 Glaxo Group Ltd Inhalador de dosis farmaceutica medida y metodos relacionados.
US7030255B2 (en) * 2004-03-09 2006-04-18 Lyondell Chemical Technology, L.P. Oxidation process with in-situ H202 generation and polymer-encapsulated catalysts therefor
EP1811981B1 (en) * 2004-10-12 2008-08-13 Merck Generics (UK) Limited Process for the preparation of suspension aerosol formulations, wherein the particles are formed by precipitation inside an aerosol canister
EP1949891A1 (en) 2004-10-12 2008-07-30 Generics (UK) Limited Process for the preparation of suspension aerosol formulations, wherein the particles are formed by precipitation inside an aerosol canister
GB0507165D0 (en) * 2005-04-08 2005-05-18 Glaxo Group Ltd Novel crystalline pharmaceutical product
GB0615108D0 (en) * 2006-07-28 2006-09-06 Glaxo Group Ltd Novel formulations
DK2425820T3 (en) 2007-02-11 2015-07-13 Map Pharmaceuticals Inc A method for the therapeutic administration of DHE in order to enable quick relief of migraine, while minimizing the adverse event profile
GB0712454D0 (en) * 2007-06-27 2007-08-08 Generics Uk Ltd Pharmaceutical compositions

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5529524A (en) * 1978-08-21 1980-03-01 Toyo Aerosol Kogyo Kk Powdery aerosol composition
US4352789A (en) * 1980-03-17 1982-10-05 Minnesota Mining And Manufacturing Company Aerosol compositions containing finely divided solid materials
GB8501015D0 (en) * 1985-01-16 1985-02-20 Riker Laboratories Inc Drug
GB8828477D0 (en) * 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
US4965066A (en) * 1989-06-06 1990-10-23 E. I. Du Pont De Nemours And Company Intranasal administration of 3,3-disubstituted indolines
AU639008B2 (en) * 1989-06-22 1993-07-15 Alliance Pharmaceutical Corporation Fluorine and phosphorous-containing amphiphilic molecules with surfactant properties
GB8921222D0 (en) * 1989-09-20 1989-11-08 Riker Laboratories Inc Medicinal aerosol formulations
IL97065A (en) * 1990-02-02 1994-01-25 Fisons Plc Repellent preparations for aerosol
DE4003272A1 (de) * 1990-02-03 1991-08-08 Boehringer Ingelheim Kg Neue treibgasmischungen und ihre verwendung in arzneimittelzubereitungen
EP0965335B1 (en) * 1990-03-23 2003-09-17 Minnesota Mining And Manufacturing Company Metered-dose aerosol formulations
AU650463B2 (en) * 1990-06-27 1994-06-23 Minnesota Mining And Manufacturing Company The use of soluble fluorosurfactants for the preparation of metered-dose aerosol formulations
US5126123A (en) * 1990-06-28 1992-06-30 Glaxo, Inc. Aerosol drug formulations

Also Published As

Publication number Publication date
IS4438A (is) 1997-03-10
CZ93697A3 (en) 1997-08-13
MX9702149A (es) 1998-04-30
NO971422L (no) 1997-05-23
FI971279A0 (fi) 1997-03-26
AP742A (en) 1999-04-26
SK281519B6 (sk) 2001-04-09
JPH10506887A (ja) 1998-07-07
EE9700061A (et) 1997-08-15
UA47412C2 (uk) 2002-07-15
MD970134A (en) 1999-02-28
MD1900C2 (ro) 2002-12-31
GB9419536D0 (en) 1994-11-16
GEP20002140B (en) 2000-06-25
NO971422D0 (no) 1997-03-25
EP0783302A1 (en) 1997-07-16
WO1996009816A1 (en) 1996-04-04
HUT77377A (hu) 1998-04-28
HU221856B1 (hu) 2003-02-28
EP0783302B1 (en) 1999-12-01
AP9700951A0 (en) 1997-04-30
KR100375469B1 (ko) 2003-10-17
CN1084614C (zh) 2002-05-15
PL181453B1 (pl) 2001-07-31
ES2140706T3 (es) 2000-03-01
IS1991B (is) 2005-02-15
ATE187063T1 (de) 1999-12-15
DK0783302T3 (da) 2000-05-29
BG101347A (en) 1997-12-30
AU707922B2 (en) 1999-07-22
CN1168630A (zh) 1997-12-24
GR3032245T3 (en) 2000-04-27
DE69513671T2 (de) 2000-04-06
BR9509108A (pt) 1998-07-14
RO118564B1 (ro) 2003-07-30
OA10603A (en) 2002-08-30
NZ292995A (en) 1998-10-28
RU2157188C2 (ru) 2000-10-10
CZ286356B6 (cs) 2000-03-15
AU3532195A (en) 1996-04-19
PL319342A1 (en) 1997-08-04
DE69513671D1 (de) 2000-01-05
SK39397A3 (en) 1997-10-08
MD1900B2 (en) 2002-04-30
KR970705981A (ko) 1997-11-03
FI971279A7 (fi) 1997-03-26
BG62839B1 (bg) 2000-09-29
FI971279L (fi) 1997-03-26
NO313658B1 (no) 2002-11-11
US5849265A (en) 1998-12-15

Similar Documents

Publication Publication Date Title
EE03380B1 (et) Farmatseutiline aerosoolpreparaat ja selle valmistamismeetod
BR9504509A (pt) Composto processo para sua preparaçao e formulaçao farmaceûtica
FI964028L (fi) Uusi farmaseuttinen formulaatio ja menetelmä
ITMI950529A0 (it) Composizioni farmaceutiche e procedimento per la loro preparazione
EE04021B1 (et) 7a-( -aminoalküül)östratrieenid, nende valmistamise meetod, 7a-( -aminoalküül)östratrieene sisaldavad farmatseutilised preparaadid ja nende kasutamine ravimite valmistamiseks
EE9700145A (et) Tsükloalkaanpüridiinid, nende valmistamismeetod, kasutamine ravimite tootmiseks ja nimetatud ühendeid sisaldavad ravimid
FI973733L (fi) Farmaseuttinen valmiste ja menetelmä sen valmistamiseksi
EE9500064A (et) Asendatud 1H-imidasoolid, nende valmistamismeetodid ja farmatseutilised kompositsioonid
BR9500784A (pt) Composto e formulação farmacêutica
BR9504060A (pt) Composto e formulação farmacêutica
FI953898A7 (fi) Glysiiniamidijohdannaisia, menetelmiä niiden valmistamiseksi ja niitä sisältäviä lääkeaineita
EE9800136A (et) Depooravimiks sobiv farmatseutiline kompositsioon, selle valmistamismeetod ja kasutamine
NO954486D0 (no) Farmasöytiske formuleringsgrunnlag
FI944961L (fi) Farmaseuttinen valmiste ja menetelmä sen valmistamiseksi
EE03338B1 (et) Tromboosivastane ravim, selle valmistamise protsess ja kasutamine
EE9800119A (et) Mikrokapseldatud putukamürgi preparaadid ja protsess nende valmistamiseks
FI953919A7 (fi) Pyrrolydeenimetyylijohdannaiset ja menetelmä niiden valmistamiseksi
FI952550A7 (fi) Uudet N-pyridyylikarboksamidit ja johdannaiset, menetelmät niiden valmistamiseksi ja niitä sisältävät farmaseuttiset koostumukset
EE9900112A (et) 2-tsüanoiminoimidasooli derivaadid, nende valmistamismeetod, kasutamine ja farmatseutilised kompositsioonid
FI941836A7 (fi) 3-deoksioligosakkaridit, menetelmiä niiden valmistamiseksi ja niitä sisältävät farmaseuttiset koostumukset
EE9800200A (et) Bensoüülguanidiini derivaadid, nende valmistamismeetod, kasutamine ja farmatseutiline kompositsioon
EE04119B1 (et) Külmkuivatamiseks sobiv ravimkoostis ja selle valmistamise meetod
FI956278A7 (fi) Substituoituja 4-fenyylitiatsolijohdannaisia, menetelmä niiden valmistamiseksi ja niitä sisältäviä farmaseuttisia koostumuksia
FI953384L (fi) Uusi bentsolitiaditsiiniyhdiste, menetelmä sen valmistamiseksi ja sitä sisältävät farmaseuttiset koostumukset
EE9800075A (et) Kombineeritud ravimpreparaat, selle kasutamine ja meetod selle valmistamiseks

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20021231

KB4A Valid patent at the end of a year

Effective date: 20031231

KB4A Valid patent at the end of a year

Effective date: 20041231

KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

MM4A Lapsed by not paying the annual fees

Effective date: 20080927